Albert Bourla Chairman, Chief Executive & Operating Officer |
Aamir Malik Chief Business Innovation Officer & Executive VP |
Sally Susman Chief Corporate Affairs Officer & Executive VP |
William Pao Chief Development Officer & Executive VP |
Brenda Cooperstone Chief Development Officer & Senior Vice President |
David M. Denton Chief Financial Officer & Executive Vice President |
Mike McDermott Chief Global Supply Officer & Executive VP |
Payal Sahni Becher Chief Human Resources Officer & Executive VP |
Aida Habtezion Chief Medical Officer |
Mikael Dolsten Chief Scientific Officer & Research President |
Donna Wartski Dir-Med Outcomes Specialist, US Medical Affairs |
Susan D. Desmond-Hellmann Director |
Denis Patrick Executive Director |
Maritza C. McIntyre Executive Director-Gene Therapy Product Lead |
Rady A. Johnson Executive VP, Chief Compliance & Risk Officer |
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer |
Douglas M. Lankler Executive Vice President & General Counsel |
Suneet Varma Global President-Rare Diseases |
Angela Hwang Group President-Biopharmaceuticals |
David DeMicco Head-Medical Affairs, Global Innovative Products |
Dan R. Littman Independent Director |
Susan J. Hockfield Independent Director |
Ronald E. Blaylock Independent Director |
Joseph J. Echevarria Independent Director |
James C. Smith Independent Director |
James Quincey Independent Director |
Suzanne Nora Johnson Independent Director |
Helen H. Hobbs Independent Director |
Bryan Dunn Investor Relations Contact |
Shantanu Narayen Lead Independent Director |
Scott Gottlieb Member of the Board of Directors |
Andy Schmeltz President-US Oncology Business Unit |
Margaret M. Madden Secretary, Chief Governance Counsel & Senior VP |
Jennifer B. Damico Senior VP-Controller & Accounting Officer |
Deborah Baron Senior VP-Worldwide Business Development |
Christopher J. Stevo Senior Vice President |
Gordon Loh Senior Vice President-Corporate Audit |
Annaliesa Anderson VP, Head-Vaccine Research & Development |
Markus Green Vice President & Assistant General Counsel |
Hakan Sakul Vice President & Head-Diagnostics |
Eva Grut-Aandahl Vice President, Head of EU Government Affairs |
Barbara J. Dalton Vice President-Worldwide Business Development |
John DeYoung Vice President-Worldwide Business Development |